Drug Database
Back to search

Netherlands· NL-9b4453df7715

Ezmekly 1 mg dispergeerbare tabletten

A mirdametinib product containing mirdametinib, registered in Netherlands by Merck Europe B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC L01EE05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedEzmekly 1 mg dispergeerbare tablettenATCL01EE05REGISTER NO.NL-9b4453df7715PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about mirdametinibAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Mirdametinib is registered in 11 of 19 countries.

Countries holding a registration under ATC L01EE05 (mirdametinib), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search mirdametinib products by name

Mirdametinib · ATC L01EE05

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Spainprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
MIRDAMETINIB
Manufacturer
Merck Europe B.V.
Country
Netherlands (NL)
ATC code
L01EE05
ATC class
Mirdametinib
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/25/1950

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Mirdametinib in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mirdametinib products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Ezmekly
  • Liechtenstein · Ezmekly
  • Norway · Ezmekly

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/001b6ac8-c1c8-4418-bda0-fc26ad9721b5
GET /v1/drugs/001b6ac8-c1c8-4418-bda0-fc26ad9721b5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Dispergeerbare tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ezmekly-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Mirdametinib",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp133931",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "DRUIVENSMAAKSTOF",
    "GLUCOSESIROOP, GEDROOGD",
    "GLYCEROLTRIACETAAT (E 1518)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL, GEMODIFICEERD",
    "SUCRALOSE (E 955)"
  ],
  "substances": [
    "MIRDAMETINIB"
  ],
  "leaflet_url": null,
  "authorised_at": "2025/07/17",
  "procedure_number": "EMEA/H/C/006460",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/25/1950",
  "additional_monitoring": "Y"
}
API referenceMCP serverPlans

See everything about mirdametinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console